Specialty drugmaker KV Pharmaceuticals has named a former Wyeth Pharmaceuticals executive as chairman of its board of directors. Joseph Mahady previously served as president of Wyeth Pharmaceuticals, where he led the company's $20 billion global medicines business.
Synthetic Biologics, Inc., a developer of biologics focused on the prevention and treatment of...
Two affiliates of SAC Capital Advisors, the hedge fund run by billionaire Steven Cohen, will pay...
NEW YORK (AP) — A former hedge fund portfolio manager charged with carrying out a record-setting...
LITTLE ROCK, Ark. (AP) — A judge has rejected a request for a new trial for an Arkansas woman who sued pharmaceutical companies Wyeth and Upjohn over the drugmakers' hormone-therapy drugs.
BUTTE, Mont. (AP) — The parents of a baby born with a serious heart defect are suing a pharmaceutical company and their physician alleging an antidepressant the mother was taking caused the defect.
GLENVIEW, Ill. (AP) — Shares of Mead Johnson Nutrition Co. rebounded in premarket trading Wednesday after a Chinese agency conceded that invalid testing led to erroneous reports that vanillin had been found in baby formula from companies including Mead Johnson.
Mylan Inc. today confirmed that the company has been sued by Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and PF Prism C.V. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.
Merck has announced the appointment of Richard R. DeLuca Jr. as executive vice president and president, Merck Animal Health, effective September 15, 2011.
NEW YORK (AP) — Pfizer Inc. said Tuesday its fourth-quarter profit nearly quadrupled from a year ago when it was weighed down by restructuring charges, as revenue rose 6 percent, thanks to the addition of products from fellow drugmaker Wyeth, acquired late in 2009.
Lupus drug developer Human Genome Sciences Inc. has appointed former Wyeth Chief Financial Officer Greg Norden to its board of directors.
As we emerge into the New Year, it is as good a time as any to take stock of where we are as an industry and what we might expect in the months to come. There can be no doubt that 2010 was a watershed year.
OKLAHOMA CITY (AP) — A federal judge in Massachusetts has granted Attorney General Drew Edmondson's request to intervene in a lawsuit against drug manufacturer Wyeth.
Today, Pfizer Inc. named Mikael Dolsten, M.D., PhD, President of Pfizer Worldwide Research and Development, as the Company completes its integration of these functions following the Wyeth acquisition.
PIERRE, S.D. (AP) — Attorney General Marty Jackley says South Dakota is seeking to join in two whistleblower lawsuits against the drugmaker Wyeth.
NEW YORK (AP) — Pfizer Inc. has reported a huge jump in its first-quarter revenue, thanks to its giant acquisition of Wyeth last October, but charges from the deal weighed down net income.
RODRIQUE NGOWI Associated Press Writer BOSTON (AP) — Federal prosecutors announced Thursday that
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 50 years, was recently presented with Wyeth's “Global Recognition for Outstanding Wyeth Suppliers” (GROWS) Award at a ceremony in Munich, Germany.
Pfizer today announced it will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has enteredinto settlement and license agreements with Wyeth, now part of Pfizer,relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules,37.
PHILADELPHIA — A jury in Philadelphia has ordered Wyeth Pharmaceuticals to pay a woman $75 million in punitive damages after finding a link between her breast cancer and a hormone-replacement drug. That's according to an attorney for the woman, Connie Barton.
LINDA A. JOHNSON AP Business Writer MARIETTA, Pa. (AP) — Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
The Associated Press Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one.
LINDA A. JOHNSON AP Business Writer TRENTON, N.J. (AP) — The world's biggest drugmaker said Monday it is closing six of its 20 research facilities, reorganizing and consolidating others, and cutting the jobs of roughly 15 percent of its scientists and support staff.
TOM PARSONS Associated Press Writer LITTLE ROCK, Ark. (AP) — Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a federal appeals court ruled Monday. The 8th U.S.
NEW YORK (AP) — Merck & Co. and Schering-Plough Corp. said Thursday they have won merger approval from the Federal Trade Commission and antitrust regulators in Switzerland and Canada. Merck hopes to close its $41.1 billion acquisition of Schering-Plough Corp. before the end of the year.
Improvements to quality systems at pharmaceutical and medical device companies can result in lower operating and compliance risk, improved ability to successfully launch new products and higher profitability. The current state of quality systems at many pharmaceutical and medical device companies is one that demands attention.
RAF CASERT Associated Press Writer BRUSSELS (AP) — The European Union approved Merck & Co.'s proposed takeover of Schering-Plough, which would create the second-biggest global producer of prescription medicines.
Warner Chilcott plc announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activities. "Dr.
- Page 1